Top Markets
Coin of the day
Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL
Clasificación en acciones #40577
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Precio por acción
$0.0036163
Última sincronización: 2023-10-30
Capitalización bursátil
$118.21K
Cambio (1 día)
0.39%
Cambio (1 año)
0.00%
País
CA
Comercio Canntab Therapeutics Limited (PILL)

Categoría

Ratio P/B de Canntab Therapeutics Limited (PILL)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Canntab Therapeutics Limited, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Canntab Therapeutics Limited desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras